nano-drug maker
Scope
Date
~
-
Batteries
Korean battery makers fret over Tesla’s cost-cutting plans
The South Korean battery industry is bracing for a grim market this year as Tesla Inc. is seeking every possible means to reduce costs to combat&nbs...
Jan 28, 2024 (Gmt+09:00)
-
Batteries
LG Energy to supply $748 million worth of batteries to Japan’s Isuzu Motors
LG Energy Solution Ltd., one of the world’s leading battery makers, has agreed to supply its cylindrical batteries to Isuzu Motors Ltd., Japan...
Jan 26, 2024 (Gmt+09:00)
-
Earnings
LG Energy leaves 2024 capex unchanged despite softer demand
LG Energy Solution Ltd. will break through the anticipated slowdown in global electric vehicle demand this year with enhanced technology leadership ...
Jan 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Electronics
Samsung Galaxy S24 sees record Indian pre-orders in three days
Samsung Electronics Co., the world’s No. 2 smartphone maker, said its latest flagship smartphone Galaxy S24 series enjoyed record pre-orders i...
Jan 23, 2024 (Gmt+09:00)
-
Earnings
Taihan Cable sees best profit in 15 years on foreign orders
Taihan Cable & Solution Co., a major South Korean cable manufacturer, on Tuesday said its 2023 operating profit hit the largest level in 15 year...
Jan 23, 2024 (Gmt+09:00)
-
Food & Beverage
HiteJinro signs land agreement for Vietnam soju plant
HiteJinro Co., a South Korean alcoholic beverage company, has signed a land agreement for its planned soju plant in Vietnam. The agreement marks a m...
Jan 23, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
Korean cosmetics makers' profits soar as niche brands grow
Kolmar Korea Co. and Cosmax Inc., South Korea’s leading cosmetics suppliers to multinational conglomerates like L'Oréal S.A., are enjoy...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
Jan 18, 2024 (Gmt+09:00)
-
Electronics
LG Innotek, AOE join hands to lead vehicle, XR camera module markets
South Korea’s major camera module maker LG Innotek Co. has joined hands with AOE Optronics Co., an automotive lens-making subsidiary of Taiwan...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Automobiles
Tata Daewoo triumphs in global market with 40% export surge
South Korea's Tata Daewoo Commercial Vehicle Company (TDCV) achieved remarkable success last year by exporting 40% of its total sales, despite the g...
Jan 16, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Samsung to double HBM chip production to lead on-device AI chip era
LAS VEGAS – Samsung Electronics Co., the world’s largest memory chipmaker, plans to more than double its high bandwidth memory (HBM) chi...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
Korea’s Hancom buys document software firm Clipsoft
Hancom Inc., a homegrown office suite developer in South Korea, said on Friday that it has acquired local business-to-business (B2B) digital documen...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Electronics
LG Display to raise $494 mn through syndicated loan
LG Display Co., the world’s leading manufacturer of organic light-emitting diode (OLED) panels, will raise 650 billion won ($494 million) by t...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Construction
HD Hyundai Construction, Infracore to use integrated machinery platform
HD Hyundai Co., a South Korean shipbuilding and machinery conglomerate, is building an integrated equipment manufacturing platform for its two const...
Dec 26, 2023 (Gmt+09:00)
-
Leadership & Management
Hankook vows to prevent hostile bids after MBK tender offer fails
Hankook & Company Co., the holding company of South Korea’s largest tire maker Hankook Tire & Technology Co., said on Tuesday it will ...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
Latest News
- 1 MBK’s Lotte Card sale gains momentum amid Homeplus fallout
- 2 Korean Air, Delta to buy 25% stake in Canada’s WestJet for $550 million
- 3 RedotPay lands in Seoul with crypto cards
- 4 Mubadala, Goldman Sachs to invest $700 mn in Kakao Mobility
- 5 Now, slim is in – and Samsung aims to be No. 1 with Galaxy S25 Edge